The organization provides expertise and funding for academic labs and early biotechs to bring emerging therapeutic approaches to the stage of human proof of concept, bridging the gap between academic innovation and industry needs. NEOMED aims to de-risk projects and add value for downstream partners by providing industrial expertise in drug discovery and development, empowering small and medium enterprises to take charge of what pharma companies were doing.